TP53 and breast carcinoma: CH exhibits anticancer effects by inhibiting the proliferation of breast cancer cells and inducing the apoptosis of cancer cells, partially through suppression of the expression of caspase-3, caspase-8, caspase-9, and TP53 [64]; (3) Down-regulating anti-apoptotic factors.